P1214: SUBCUTANEOUS EPCORITAMAB + R-CHOP FOR FIRST-LINE TREATMENT OF PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA: PHASE 1/2 UPDATE

• DOI: 10.1097/01.hs9.0000847720.26592.b6
• Publication Date: 2022-06-23T14:26:54Z
• Authors: M. R. Clausen; F. Offner; D. Belada; J. Brody; K. M. Linton; Y. Karimi; R. Cordoba; S. Snauwaert; A. Abbas; L. Wang; J. Wu; B. Elliott; L. Falchi
• Keywords: 03 medical and health sciences; 0302 clinical medicine; Posters; Diseases of the blood and blood-forming organs; RC633-647.5